Skip to main content
. 2023 Jan 22;15(2):378. doi: 10.3390/pharmaceutics15020378

Table 3.

Experimental plan based on central composite design.

Run Homogenisation Time (min) Ultrasonication Time (min) Amplitude (%)
1 5 10 50
2 10 10 50
3 5 20 50
4 10 20 50
5 5 10 70
6 10 10 70
7 5 20 70
8 10 20 70
9 5 15 60
10 10 15 60
11 7.5 10 60
12 7.5 20 60
13 7.5 15 50
14 7.5 15 70
15 7.5 15 60
16 7.5 15 60
17 7.5 15 60